{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:35:23Z","timestamp":1782797723233,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology Practice"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.cnp.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T05:47:38Z","timestamp":1707889658000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Without ENMG, detecting pediatric vincristine neuropathy is a challenge"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8452-1344","authenticated-orcid":false,"given":"Kreeta","family":"Viinikainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-1614","authenticated-orcid":false,"given":"Pirjo","family":"Isohanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"L\u00f6nnqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1102-2945","authenticated-orcid":false,"given":"Leena","family":"Lauronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cnp.2024.01.005_b0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2217\/pgs-2018-0093","article-title":"Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing","volume":"19","author":"Abaji","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cnp.2024.01.005_b0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pbc.23039","article-title":"Neuropathic pain during treatment for childhood acute lymphoblastic leukemia","volume":"57","author":"Anghelescu","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.cnp.2024.01.005_b0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02759902","article-title":"Vincristine induced cranial polyneuropathy","volume":"73","author":"Bay","year":"2006","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.cnp.2024.01.005_b0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S2352-4642(18)30236-0","article-title":"Peripheral neuropathy in children and adolescents treated for cancer","volume":"2","author":"Bjornard","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cnp.2024.01.005_b0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cnp.2024.01.005_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/96.1.69","article-title":"Vincristine neuropathy. Clinical and electrophysiological observations","volume":"96","author":"Casey","year":"1973","journal-title":"Brain"},{"key":"10.1016\/j.cnp.2024.01.005_b0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/pgs.14.68","article-title":"Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia","volume":"15","author":"Ceppi","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cnp.2024.01.005_b0040","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cnp.2024.01.005_b0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/mus.24647","article-title":"Vincristine-induced neuropathy: atypical electrophysiological patterns in children","volume":"52","author":"Courtemanche","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cnp.2024.01.005_b0050","first-page":"138","article-title":"Evaluation of neuropathy during intensive vincristine chemotherapy for non-Hodgkin\u2019s lymphoma and Acute Lymphoblastic Leukemia","volume":"3","author":"Dorchin","year":"2013","journal-title":"Iran J. Ped. Hematol. Oncol."},{"key":"10.1016\/j.cnp.2024.01.005_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01893697-200927030-00002","article-title":"Measuring chemotherapy-induced peripheral neuropathy in children: development of the Ped-mTNS and Pilot study results","volume":"27","author":"Gilchrist","year":"2009","journal-title":"Rehabil. Oncol."},{"key":"10.1016\/j.cnp.2024.01.005_b0060","first-page":"355","article-title":"Early phase of vincristine neuropathy in man. Electrophysiological evidence for a dying-back phenomenon, with transitory enhancement of spinal transmission of the monosynaptic reflex","volume":"45","author":"Gulheneuc","year":"1980","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cnp.2024.01.005_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1188\/17.ONF.E111-E123","article-title":"Chemotherapy-induced peripheral neuropathy assessment tools: a systematic review","volume":"44","author":"Haryani","year":"2017","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.cnp.2024.01.005_b0070","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cnp.2024.01.005_b0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0883073813491829","article-title":"Vincristine-induced neuropathy in childhood all (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics","volume":"29","author":"Jain","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.cnp.2024.01.005_b0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctrv.2016.09.005","article-title":"Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge","volume":"50","author":"Kandula","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cnp.2024.01.005_b0085","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cnp.2024.01.005_b0090","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.clinph.2020.06.035","article-title":"Peripheral nerve maturation and excitability properties from early childhood: comparison of motor and sensory nerves","volume":"131","author":"Kandula","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2024.01.005_b0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MPH.0000000000000825","article-title":"Electrophysiological studies to detect peripheral neuropathy in children treated with vincristine","volume":"39","author":"Kavcic","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cnp.2024.01.005_b0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1188\/08.ONF.96-102","article-title":"The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy","volume":"35","author":"Lavoie Smith","year":"2008","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.cnp.2024.01.005_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/NCC.0b013e318299ad23","article-title":"Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"36","author":"Lavoie Smith","year":"2013","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.cnp.2024.01.005_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1043454220980253","article-title":"Assessment of pediatric chemotherapy-induced peripheral neuropathy using a new patient-reported outcome measure: the P-CIN","volume":"38","author":"Lavoie Smith","year":"2021","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"10.1016\/j.cnp.2024.01.005_b0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.cnp.2024.01.005_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clinph.2023.08.002","article-title":"Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia","volume":"154","author":"Li","year":"2023","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2024.01.005_b0125","first-page":"124","article-title":"Chemotherapy-induced peripheral neuropathy in pediatric cancer patients","volume":"14","author":"Moore","year":"2013","journal-title":"Cureus"},{"key":"10.1016\/j.cnp.2024.01.005_b0130","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cnp.2024.01.005_b0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases","volume":"55","author":"Moriyama","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.cnp.2024.01.005_b0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1529-8027.2009.00230.x","article-title":"Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia","volume":"14","author":"Ramchandren","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.cnp.2024.01.005_b0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/ejpn.1999.0310","article-title":"Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia","volume":"4","author":"Reinders-Messelink","year":"2000","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.cnp.2024.01.005_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1043454218762705","article-title":"Assessment tools for peripheral neuropathy in pediatric oncology: a systematic review from the children\u2019s oncology group","volume":"35","author":"Smolik","year":"2018","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"10.1016\/j.cnp.2024.01.005_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26471","article-title":"Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia","volume":"64","author":"Tay","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.cnp.2024.01.005_b0160","first-page":"351","article-title":"Electrophysiological consequences of vincristine contained chemotherapy in children: a cohort study","volume":"7","author":"Toopchizadeh","year":"2009","journal-title":"J. Pediatr. Neurol."},{"key":"10.1016\/j.cnp.2024.01.005_b0165","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/ijms22084112","article-title":"Vincristine-induced peripheral neuropathy (VIPN) in pediatric tumors: mechanisms, risk factors, strategies of prevention and treatment","volume":"22","author":"Triarico","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cnp.2024.01.005_b0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2017.04.004","article-title":"Vincristine-induced peripheral neuropathy in children with cancer: a systematic review","volume":"114","author":"van de Velde","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cnp.2024.01.005_b0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/01616412.2016.1139321","article-title":"Vincristine-induced neurotoxicity: electrophysiological features in children","volume":"38","author":"Yildiz","year":"2016","journal-title":"Neurol. Res."}],"container-title":["Clinical Neurophysiology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X24000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X24000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T13:54:57Z","timestamp":1734616497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2467981X24000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":35,"alternative-id":["S2467981X24000088"],"URL":"https:\/\/doi.org\/10.1016\/j.cnp.2024.01.005","relation":{},"ISSN":["2467-981X"],"issn-type":[{"value":"2467-981X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Without ENMG, detecting pediatric vincristine neuropathy is a challenge","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnp.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}